Notice: 函数 WP_Styles::add 的调用方法不正确。 The style with the handle "storefront-woocommerce-style" was enqueued with dependencies that are not registered: storefront-style. 请查阅调试 WordPress来获取更多信息。 (这个消息是在 6.9.1 版本添加的。) in /wordpress/wp-includes/functions.php on line 6260

KC-1499

MC38-CD19-Cell-Line

Home » MC38-CD19-Cell-Line

Background of MC38-CD19-Cell-Line

CD19 is a type I transmembrane glycoprotein that functions as coreceptor for the B cell antigen receptor complex (BCR) on B cell lymphocytes, and plays a vital role in humoral immune response. CD19 is expressed throughout B cell development from pre-B-cell differentiation with expression persisting until terminal differentiation into plasma cells, and is commonly used as B cell lineage marker; CD19 is also found on most B cell malignancies including chronic lymphocytic leukemias (CLLs), B cell non- Hodgkin’s lymphomas (NHLs), and more aggressive B-ALL, which lead to the rapid development of therapeutic antibodies and chimeric antigen receptor therapy.

Specifications

Catalog Number:
KC-1499-DW
Cell Line Name:
MC38-CD19
Clone Number
Host Cell Line:
Mouse MC38 cell line
Description:
MC38 cell line stable expressing exogenous human CD19 gene
Quantity:
Two vials of frozen cells (2-5×106/vial)
Stability:
Stable in culture over a minimum of 10 passages
Application:
Drug screening and biological assays
Freezing Medium:
70% RPMI1640+20% FBS+10% DMSO
Propagation Medium:
RPMI1640+10%FBS+5µg/mL Puromycin
Selection Marker:
Puromycin
Morphology:
Epithelial
Subculture:
Split saturated culture 1:2-1:5 every 3 days; seed out at about 1-3 × 105 cells/mL
Incubation:
37 °C with 5% CO2
Storage:
Liquid nitrogen immediately upon receiving
Doubling Time:
Approximately 48 hours
Mycoplasma Status:
Negative
In Vivo Validation:
Yes

Cell Line Generation

MC38 human CD19 cell line was generated using lentiviral vector expressing human CD19 sequence.

Characterization

Cell Resuscitation

  1. Prewarm culture medium (RPMI1640 + 10% FBS + 5µg/mL Puromycin)in a 37°C water bath.
  2. Thaw the frozen vial in a 37°C water bath for 1-2 minutes.
  3. Transfer the vial into biosafety cabinet, and wipe the surface with 70% ethanol.
  4. Unscrew the top of the vial and transfer the cell suspension gently into a sterile centrifuge tube containing 9.0mL complete culture medium.
  5. Spin at ~ 125 × g for 5-7 minutes at room temperature, and discard the supernatant without disturbing the pellet.
  6. Resuspend cell pellet with the appropriate volume of complete medium and transfer the cell suspension into a T25 culture flask.
  7. Incubate the flask at 37°C, 5% CO2 incubator.
  8. Split saturated culture 1:2-1:5 every 3 days; seed out at about 1-3 × 105 cells/mL.

Cell Freezing

  1. Prepare the freezing medium (70% RPMI-1640 + 20% FBS + 10% DMSO) fresh immediately before use.
  2. Keep the freezing medium on ice and label cryovials.
  3. Transfer cells to a sterile, conical centrifuge tube, and count the cells.
  4. Centrifuge the cells at 250×g for 5 minutes at room temperature and carefully aspirate off the medium.
  5. Resuspend the cells at a density of at least 3×106 cells/mL in chilled freezing medium.
  6. Aliquot 1 mL of the cell suspension into each cryovial.
  7. Freeze cells in the CoolCell freezing container overnight in a -80°C freezer.
  8. Transfer vials to liquid nitrogen for long-term storage

References

  1. Zhou, L., Ord, D., Omori, S. & Tedder, T. Structure of the genes encoding the CD19 antigen of human and mouse B lymphocytes. Immunogenetics 35, 102ÿ111 (1992).
  2. Brentjens, R. J. et al. CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapyrefractory acute lymphoblastic leukemia. Sci. Transl. Med. 5, (2013).